| scholarly article | Q13442814 |
| P50 | author | Randa Kasmieh | Q125261420 |
| Ralph Weissleder | Q7288259 | ||
| P2093 | author name string | Anna M Krichevsky | |
| Khalid Shah | |||
| Maarten F Corsten | |||
| Rafael Miranda | |||
| P433 | issue | 19 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cytotoxicity | Q246181 |
| microRNA | Q310899 | ||
| P304 | page(s) | 8994-9000 | |
| P577 | publication date | 2007-10-01 | |
| P1433 | published in | Cancer Research | Q326097 |
| P1476 | title | MicroRNA-21 knockdown disrupts glioma growth in vivo and displays synergistic cytotoxicity with neural precursor cell delivered S-TRAIL in human gliomas | |
| P478 | volume | 67 |
| Q52784405 | A Functional MicroRNA Screening Method for Organ Morphogenesis. |
| Q35025917 | A high-throughput screen identifies miRNA inhibitors regulating lung cancer cell survival and response to paclitaxel. |
| Q38356196 | A major role for microRNAs in glioblastoma cancer stem-like cells |
| Q39535302 | A miR-21 inhibitor enhances apoptosis and reduces G(2)-M accumulation induced by ionizing radiation in human glioblastoma U251 cells |
| Q30409365 | A miR-297/hypoxia/DGK-α axis regulating glioblastoma survival |
| Q39744489 | A novel molecule integrating therapeutic and diagnostic activities reveals multiple aspects of stem cell-based therapy. |
| Q38334606 | A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs |
| Q34293659 | A novel ultrasensitive hybridization-based ELISA method for 2-methoxyphosphorothiolate microRNAs and its in vitro and in vivo application |
| Q24633772 | A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasion |
| Q37690850 | AKT Axis, miR-21, and RECK Play Pivotal Roles in Dihydroartemisinin Killing Malignant Glioma Cells. |
| Q38161369 | Aberrant signaling pathways in glioma. |
| Q64252260 | Acute Spinal Cord Injury: A Systematic Review Investigating miRNA Families Involved |
| Q37395054 | Allele-specific silencing of mutant huntingtin and ataxin-3 genes by targeting expanded CAG repeats in mRNAs |
| Q43277481 | Alteration of microRNA expression in vinyl carbamate-induced mouse lung tumors and modulation by the chemopreventive agent indole-3-carbinol |
| Q39930107 | An autoregulatory loop mediated by miR-21 and PDCD4 controls the AP-1 activity in RAS transformation |
| Q30551524 | An integrative characterization of recurrent molecular aberrations in glioblastoma genomes |
| Q45855761 | Anti-cancer effect of R3V6 peptide-mediated delivery of an anti-microRNA-21 antisense-oligodeoxynucleotide in a glioblastoma animal model |
| Q35556517 | Anti-miR-203 Upregulates SOCS3 Expression in Breast Cancer Cells and Enhances Cisplatin Chemosensitivity |
| Q35653261 | Antiangiogenic variant of TSP-1 targets tumor cells in glioblastomas |
| Q36965370 | Applications of emerging molecular technologies in glioblastoma multiforme |
| Q37483966 | Applications of neural and mesenchymal stem cells in the treatment of gliomas |
| Q33645912 | Assessment of concentrations of sTRAIL ligand and its receptors sTRAIL-R1 and sTRAIL-R2 - markers monitoring the course of the extrinsic pathway of apoptosis induction: potential application in ovarian cancer diagnostics |
| Q37140126 | Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy |
| Q38112723 | Canonical and non-canonical barriers facing antimiR cancer therapeutics |
| Q93347094 | Characterization of Transcriptome Transition Associates Long Noncoding RNAs with Glioma Progression |
| Q34157966 | Chromatin-modifying drugs induce miRNA-153 expression to suppress Irs-2 in glioblastoma cell lines |
| Q38765826 | Co-delivery of pemetrexed and miR-21 antisense oligonucleotide by lipid-polymer hybrid nanoparticles and effects on glioblastoma cells. |
| Q38960128 | Combination of systemic chemotherapy with local stem cell delivered S-TRAIL in resected brain tumors |
| Q48158056 | Comparison of microRNA expression levels between initial and recurrent glioblastoma specimens. |
| Q38830931 | Convection-enhanced delivery of an anti-miR is well-tolerated, preserves anti-miR stability and causes efficient target de-repression: a proof of concept |
| Q36785112 | Coordination of self-renewal in glioblastoma by integration of adhesion and microRNA signaling |
| Q38034755 | Current Progress on Understanding MicroRNAs in Glioblastoma Multiforme |
| Q38102611 | Current progress for the use of miRNAs in glioblastoma treatment |
| Q28277249 | De-repression of CTGF via the miR-17-92 cluster upon differentiation of human glioblastoma spheroid cultures |
| Q37277384 | Delivery of RNAi-Based Oligonucleotides by Electropermeabilization |
| Q38921973 | Delivery of anti-microRNA-21 antisense-oligodeoxynucleotide using amphiphilic peptides for glioblastoma gene therapy |
| Q36920080 | Design and delivery of antisense oligonucleotides to block microRNA function in cultured Drosophila and human cells. |
| Q50098046 | Development and characterization of cationic solid lipid nanoparticles for co-delivery of pemetrexed and miR-21 antisense oligonucleotide to glioblastoma cells. |
| Q64099533 | Development of miRNA-based therapeutic approaches for cancer patients |
| Q34986356 | Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1. |
| Q33911224 | Differential expression of miR200a-3p and miR21 in grade II-III and grade IV gliomas: evidence that miR200a-3p is regulated by O⁶-methylguanine methyltransferase and promotes temozolomide responsiveness |
| Q35021340 | Downregulation of Pdcd4 by mir-21 facilitates glioblastoma proliferation in vivo |
| Q39756064 | Downregulation of miR-21 inhibits EGFR pathway and suppresses the growth of human glioblastoma cells independent of PTEN status |
| Q36351084 | Dysregulation of microRNAs in cancer |
| Q37779828 | Dysregulation of microRNAs in cancer: playing with fire |
| Q39281860 | Effect of miR-21 and miR-30b/c on TRAIL-induced apoptosis in glioma cells. |
| Q37439491 | Emerging functions of microRNAs in glioblastoma |
| Q38127635 | Emerging roles of microRNA in modulating cell-death processes in malignant glioma |
| Q37272418 | Emerging roles of microRNAs as molecular switches in the integrated circuit of the cancer cell. |
| Q48090086 | Expression level of miRNAs on chromosome 14q32.31 region correlates with tumor aggressiveness and survival of glioblastoma patients. |
| Q38777383 | Extracellular Vesicles and MicroRNAs: Their Role in Tumorigenicity and Therapy for Brain Tumors |
| Q24305974 | Foxo3a regulates apoptosis by negatively targeting miR-21 |
| Q38236031 | Functional role of miRNA in cardiac resynchronization therapy |
| Q90162787 | Glioblastoma-Associated Microglia Reprogramming Is Mediated by Functional Transfer of Extracellular miR-21 |
| Q34310698 | Gliomagenesis and the use of neural stem cells in brain tumor treatment |
| Q37492187 | High-throughput microRNA profiling of pediatric high-grade gliomas. |
| Q34055926 | Identification and characterization of a novel non-coding RNA involved in sperm maturation |
| Q28389846 | Identification of a core miRNA-pathway regulatory network in glioma by therapeutically targeting miR-181d, miR-21, miR-23b, β-Catenin, CBP, and STAT3 |
| Q39878140 | Identification of miR-21 targets in breast cancer cells using a quantitative proteomic approach |
| Q30854013 | Identification of miRNA-7 by genome-wide analysis as a critical sensitizer for TRAIL-induced apoptosis in glioblastoma cells |
| Q28473944 | Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer |
| Q91784729 | Identification of microRNA-21 target genes associated with hair follicle development in sheep |
| Q21135016 | Identification of microRNAs as potential prognostic markers in ependymoma |
| Q34566039 | Important miRs of pathways in different tumor types |
| Q36213745 | Inferring transcriptional and microRNA-mediated regulatory programs in glioblastoma |
| Q36799623 | Inhibition of miR-21 in glioma cells using catalytic nucleic acids |
| Q35025350 | Involvement of miRNAs in the differentiation of human glioblastoma multiforme stem-like cells |
| Q34771731 | Involvement of microRNAs in lung cancer biology and therapy |
| Q54401190 | Knockdown of microRNA-21 inhibits proliferation and increases cell death by targeting programmed cell death 4 (PDCD4) in pancreatic ductal adenocarcinoma. |
| Q36142470 | LNA-based oligonucleotide electrotransfer for miRNA inhibition |
| Q21183973 | Large-scale data integration framework provides a comprehensive view on glioblastoma multiforme |
| Q35879903 | Loss of brain-enriched miR-124 microRNA enhances stem-like traits and invasiveness of glioma cells |
| Q36544941 | Loss of miR-204 expression enhances glioma migration and stem cell-like phenotype |
| Q36092724 | Mesenchymal stem cells engineered for cancer therapy |
| Q39240322 | MiR-16-1 plays a role in reducing migration and invasion of glioma cells. |
| Q39371347 | MiR-483-5p suppresses the proliferation of glioma cells via directly targeting ERK1. |
| Q89880080 | Micro RNA Molecules as Modulators of Treatment Resistance, Immune Checkpoints Controllers and Sensitive Biomarkers in Glioblastoma Multiforme |
| Q33614641 | MicroRNA 128a increases intracellular ROS level by targeting Bmi-1 and inhibits medulloblastoma cancer cell growth by promoting senescence |
| Q24336898 | MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators |
| Q41208796 | MicroRNA Regulation of Glycolytic Metabolism in Glioblastoma. |
| Q38770220 | MicroRNA and extracellular vesicles in glioblastoma: small but powerful |
| Q64899756 | MicroRNA based theranostics for brain cancer: basic principles. |
| Q35163580 | MicroRNA dysregulation following spinal cord contusion: implications for neural plasticity and repair. |
| Q86827722 | MicroRNA expression profiling in peritoneal fibrosis |
| Q36807876 | MicroRNA expression profiling of sputum for the detection of early and locally advanced non-small-cell lung cancer: a prospective case-control study |
| Q34409620 | MicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme--a systematic overview. |
| Q47142132 | MicroRNA in Glioblastoma: An Overview |
| Q27001048 | MicroRNA in cancer: new hopes for antineoplastic chemotherapy |
| Q37069474 | MicroRNA involvement in brain tumors: from bench to bedside |
| Q35105405 | MicroRNA signatures differentiate Crohn's disease from ulcerative colitis |
| Q40017158 | MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer |
| Q37745975 | MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9. |
| Q37726121 | MicroRNA-185 regulates chemotherapeutic sensitivity in gastric cancer by targeting apoptosis repressor with caspase recruitment domain |
| Q39342199 | MicroRNA-21 expression is regulated by β-catenin/STAT3 pathway and promotes glioma cell invasion by direct targeting RECK. |
| Q38070646 | MicroRNA-21 gene and cancer |
| Q33527586 | MicroRNA-21 inhibitor sensitizes human glioblastoma cells U251 (PTEN-mutant) and LN229 (PTEN-wild type) to taxol |
| Q84245716 | MicroRNA-21 is involved in osteosarcoma cell invasion and migration |
| Q36580732 | MicroRNA-21 silencing enhances the cytotoxic effect of the antiangiogenic drug sunitinib in glioblastoma |
| Q36849434 | MicroRNA-495 inhibits proliferation of glioblastoma multiforme cells by downregulating cyclin-dependent kinase 6 |
| Q35038680 | MicroRNA-584 functions as a tumor suppressor and targets PTTG1IP in glioma |
| Q46190130 | MicroRNA-target cross-talks: Key players in glioblastoma multiforme |
| Q34878670 | MicroRNA: A matter of life or death |
| Q35949461 | MicroRNAs and Gastroenterological Cancers |
| Q37517191 | MicroRNAs and glioblastoma; the stem cell connection |
| Q38184973 | MicroRNAs and human diseases: diagnostic and therapeutic potential |
| Q38064494 | MicroRNAs and lymphomagenesis: a functional review |
| Q35994443 | MicroRNAs and other non-coding RNAs as targets for anticancer drug development |
| Q33712700 | MicroRNAs as new players in the genomic galaxy and disease puzzles |
| Q37827156 | MicroRNAs as potential target gene in cancer gene therapy of gastrointestinal tumors |
| Q37567440 | MicroRNAs as regulators of death receptors signaling |
| Q37897499 | MicroRNAs as regulators of neural stem cell-related pathways in glioblastoma multiforme |
| Q37032639 | MicroRNAs as targets for antisense-based therapeutics |
| Q38303604 | MicroRNAs in Human Pituitary Adenomas |
| Q38219675 | MicroRNAs in brain metastases: potential role as diagnostics and therapeutics. |
| Q30437444 | MicroRNAs in cancer |
| Q38057979 | MicroRNAs in cancer diagnosis and therapy: from bench to bedside |
| Q26747273 | MicroRNAs in glioblastoma multiforme pathogenesis and therapeutics |
| Q37974078 | MicroRNAs in neural cell development and brain diseases |
| Q38027374 | MicroRNAs: a light into the "black box" of neuropediatric diseases? |
| Q37287182 | MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death |
| Q33346479 | MicroRNAs: regulators of oncogenesis and stemness |
| Q37120216 | Modulation of miRNA activity in human cancer: a new paradigm for cancer gene therapy? |
| Q37110373 | Molecular imaging strategies for in vivo tracking of microRNAs: a comprehensive review |
| Q36512525 | Multimechanistic tumor targeted oncolytic virus overcomes resistance in brain tumors |
| Q91893133 | Nanoparticle-mediated intratumoral inhibition of miR-21 for improved survival in glioblastoma |
| Q36335668 | Neuroplasticity, axonal guidance and micro-RNA genes are associated with morphine self-administration behavior |
| Q37971309 | Neurotransplantation: lux et veritas, fiction or reality? |
| Q39868687 | No small matter: microRNAs - key regulators of cancer stem cells |
| Q33762263 | Non-coding RNAs: a key to future personalized molecular therapy? |
| Q38885495 | Noncoding RNAs in Therapeutic Resistance of Cancer |
| Q27006099 | Novel delivery strategies for glioblastoma |
| Q42111511 | Nucleic acids in human glioma treatment: innovative approaches and recent results |
| Q47811340 | Overexpressed miR-128a enhances chemoradiotherapy to laryngeal cancer cells and its correlation with BMI1. |
| Q28396088 | Overexpression of secretagogin inhibits cell apoptosis and induces chemoresistance in small cell lung cancer under the regulation of miR-494 |
| Q38322616 | PEI-complexed LNA antiseeds as miRNA inhibitors |
| Q55463671 | Potential role of miRNAs and their inhibitors in glioma treatment. |
| Q41850806 | Regulation of the mammalian nervous system by microRNAs |
| Q53257500 | Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinoma. |
| Q41785826 | Relevance of Rabbit VX2 Tumor Model for Studies on Human Hepatocellular Carcinoma: A MicroRNA-Based Study |
| Q33850064 | Resistance to cancer chemotherapeutic drugs is determined by pivotal microRNA regulators |
| Q33370714 | Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres |
| Q39136190 | Resveratrol repressed viability of U251 cells by miR-21 inhibiting of NF-κB pathway |
| Q37617262 | Role of 3'-untranslated region translational control in cancer development, diagnostics and treatment |
| Q38346740 | Role of the AKT pathway in microRNA expression of human U251 glioblastoma cells |
| Q37134134 | Short non-coding RNA biology and neurodegenerative disorders: novel disease targets and therapeutics |
| Q34450866 | Silencing of microRNA-21 confers radio-sensitivity through inhibition of the PI3K/AKT pathway and enhancing autophagy in malignant glioma cell lines |
| Q36934643 | Similar dose-dependence of motor neuron cell death caused by wild type human TDP-43 and mutants with ALS-associated amino acid substitutions |
| Q37638475 | Small molecule modifiers of the microRNA and RNA interference pathway |
| Q37906461 | Stem cell microRNAs in senescence and immortalization: novel players in cancer therapy |
| Q34240433 | Stem cells as therapeutic vehicles for the treatment of high-grade gliomas |
| Q37029450 | Sub-cellular temporal and spatial distribution of electrotransferred LNA/DNA oligomer |
| Q37433463 | TRAIL on trial: preclinical advances in cancer therapy |
| Q37799840 | Targeting miR-21 in glioma: a small RNA with big potential |
| Q38058733 | Targeting microRNAs to modulate TRAIL-induced apoptosis of cancer cells |
| Q37356520 | Targeting multiple pathways in gliomas with stem cell and viral delivered S-TRAIL and Temozolomide |
| Q35181388 | The NFL-TBS.40-63 anti-glioblastoma peptide disrupts microtubule and mitochondrial networks in the T98G glioma cell line |
| Q24657924 | The PTEN-regulating microRNA miR-26a is amplified in high-grade glioma and facilitates gliomagenesis in vivo |
| Q34220723 | The clinical potential of microRNAs |
| Q34278112 | The duality of oncomiR addiction in the maintenance and treatment of cancer |
| Q30426792 | The elephant in the room: do microRNA-based therapies have a realistic chance of succeeding for brain tumors such as glioblastoma? |
| Q37439475 | The evolution and application of techniques in molecular biology to human brain tumors: a 25 year perspective. |
| Q55463784 | The many functions of microRNAs in glioblastoma. |
| Q33754114 | The new concepts on overcoming drug resistance in lung cancer |
| Q37765520 | The role of MicroRNA in chemical carcinogenesis |
| Q37476789 | The role of autophagy in sensitizing malignant glioma cells to radiation therapy |
| Q35652587 | The role of miR-124a in early development of the Xenopus eye. |
| Q30428370 | The role of microRNAs in glioma initiation and progression |
| Q38598965 | Therapeutic Targeting of microRNAs in Cancer: Future Perspectives |
| Q39198277 | Therapeutic efficacy and fate of bimodal engineered stem cells in malignant brain tumors |
| Q24651333 | Therapeutic microRNA strategies in human cancer |
| Q48219725 | Therapeutic prospects of microRNAs in cancer treatment through nanotechnology |
| Q37122166 | Therapeutic stem-cells for cancer treatment: hopes and hurdles in tactical warfare |
| Q50532322 | Toxicity study of ochratoxin A using HEK293 and HepG2 cell lines based on microRNA profiling. |
| Q28914781 | Transfection of small RNAs globally perturbs gene regulation by endogenous microRNAs |
| Q35597051 | Translational study of microRNAs and its application in kidney disease and hypertension research |
| Q38703769 | Tumor suppressors microRNA-302d and microRNA-16 inhibit human glioblastoma multiforme by targeting NF-κB and FGF2. |
| Q37567452 | Viruses, gene therapy and stem cells for the treatment of human glioma. |
| Q38259177 | cAMP-Epac Pathway Stimulation Modulate Connexin-43 and MicroRNA-21 Expression in Glioma Cells |
| Q21245271 | miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells |
| Q37191655 | miR-124 inhibits STAT3 signaling to enhance T cell-mediated immune clearance of glioma |
| Q24634704 | miR-145-mediated suppression of cell growth, invasion and metastasis |
| Q34931601 | miR-21: a small multi-faceted RNA. |
| Q39749407 | miR-21: an oncomir on strike in prostate cancer. |
| Q83034995 | miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1 |
| Q26992374 | miRNA and mammalian male germ cells |
| Q38092617 | miRNA-Based Therapeutic Strategies |
| Q33629095 | microRNA 21: response to hormonal therapies and regulatory function in leiomyoma, transformed leiomyoma and leiomyosarcoma cells |
| Q38521725 | microRNA therapies in cancer |
| Q39013257 | microRNA-495 inhibits chondrogenic differentiation in human mesenchymal stem cells by targeting Sox9 |
| Q36983175 | microRNAs and death receptors. |
| Q37655925 | microRNAs in acute myeloid leukemia: expression patterns, correlations with genetic and clinical parameters, and prognostic significance |
| Q37592046 | microRNAs in gliomas: small regulators of a big problem |
| Q37784515 | microRNAs: Master Regulators as Potential Therapeutics in Cancer |
| Q35075522 | mirConnX: condition-specific mRNA-microRNA network integrator |
Search more.